Phyllodes tumour: Difference between revisions
Jump to navigation
Jump to search
| Line 133: | Line 133: | ||
Epithelial component: | Epithelial component: | ||
*CK7 +ve. | *CK7 +ve. | ||
*ER. | |||
*PR. | |||
Stromal cells:<ref>{{cite journal |authors=Dunne B, Lee AH, Pinder SE, Bell JA, Ellis IO |title=An immunohistochemical study of metaplastic spindle cell carcinoma, phyllodes tumor and fibromatosis of the breast |journal=Hum Pathol |volume=34 |issue=10 |pages=1009–15 |date=October 2003 |pmid=14608534 |doi=10.1053/s0046-8177(03)00414-3 |url=}}</ref> | Stromal cells:<ref>{{cite journal |authors=Dunne B, Lee AH, Pinder SE, Bell JA, Ellis IO |title=An immunohistochemical study of metaplastic spindle cell carcinoma, phyllodes tumor and fibromatosis of the breast |journal=Hum Pathol |volume=34 |issue=10 |pages=1009–15 |date=October 2003 |pmid=14608534 |doi=10.1053/s0046-8177(03)00414-3 |url=}}</ref> | ||
*CD34 +ve. | *CD34 +ve. | ||
Revision as of 20:50, 1 September 2026
| Phyllodes tumour | |
|---|---|
| Diagnosis in short | |
|
Phyllodes tumour. H&E stain. | |
|
| |
| LM | either (1) or (2): (1) large slit-like spaces, (2) cellular stroma - may be myxoid; +/-infiltrative border, +/-mitoses, +/-nuclear atypia, +/-"stromal overgrowth" ~ stroma fills microscopic field (see microscopic section) |
| Subtypes | benign, borderline, malignant |
| LM DDx | fibroadenoma, metaplastic breast carcinoma, primary breast sarcoma, other sarcomas |
| Gross | mass with clefts - leaf-like structures |
| Site | breast |
|
| |
| Signs | mass lesion |
| Prevalence | uncommon |
| Prognosis | usually benign, may be malignant |
| Clin. DDx | other breast tumours - often fibroadenoma |
| Treatment | wide excision |
Phyllodes tumour is a tumour of the intralobular breast stroma. It may be benign or malignant.
It was previously called cystosarcoma phyllodes. It is a type of fibroepithelial tumour.
General
- The name comes from the word "leaf".
- With imagination or psychotropic drugs, it may look like one: the epithelial component = the veins of the leaf.
- Wide excision -- this differs from fibroadenoma (just local excision).
- Approximately 6% are malignant.[1]
Notes:
- There are case reports of phyllodes tumours in the prostate gland.[2]
- Outside of the breast a phyllodes-like histomorphology may represent an adenosarcoma.[3]
Gross
- Clefts/leaf-like structures.
- Friable - especially vis-à-vis a fibroadenoma.
Image:
Microscopic
Features - either 1, 2 or both of the following:
- Large slit-like spaces - key feature. †
- Cellular stroma - key feature. †
- May be myxoid.
- +/-Infiltrative border.
- +/-Mitoses.
- +/-Nuclear atypia.
- +/-"Stromal overgrowth" ~ stroma fills microscopic field (see below).
Notes:
- † Large slit-like spaces are required for a benign phyllodes tumour.
- Slit-like spaces may absent in a borderline phyllodes or a malignant phyllodes.
- A cellular tumour without features suggestive of malignancy and without slit-like spaces is a cellular fibroadenoma.
- Some pathologists don't believe in cellular fibroadenoma - they call everything with stromal cellularity a phyllodes tumour.[4]
DDx:
- Fibroadenoma.
- Metaplastic breast carcinoma.
- Primary breast sarcoma.
- Other sarcomas.
Images
-
Phyllodes tumour - very low mag. (WC/Nephron)
-
Phyllodes tumour - low mag. (WC/Nephron)
-
Malignant phyllodes tumour - low mag (WC)
-
Malignant phyllodes tumour - high mag (WC)
Grading
Phyllodes tumours are graded:
- Benign.
- Borderline.
- Malignant.
Grading phyllodes tumours - based on WMSP:[5]
| Feature | Benign phyllodes | Borderline phyllodes | Malignant phyllodes |
|---|---|---|---|
| Circumscription | Well | Well | Poor |
| Stromal overgrowth † | none | none | may be present |
| Nuclear atypia | mild | mild-to-moderate | moderate-to-marked |
| Mitoses per 10 HPFs ‡ | < 5 | 5-10 | >10 |
| Heterologous elements | +/- benign | +/- benign | +/- malignant |
| DDx | fibroadenoma | benign phyllodes, malignant phyllodes | metaplastic breast carcinoma, sarcoma |
Notes:
- † Stromal overgrowth = epithelial elements absent in one low power field (LPF), defined as x40;[6] LPF is not adequately defined - see LPFitis.
- ‡ HPF is not adequately defined - see HPFitis.
IHC
Epithelial component:
- CK7 +ve.
- ER.
- PR.
Stromal cells:[7]
- CD34 +ve.
- BCL2 +ve.
- CK -ve.
Sign out
Benign
Right Breast Mass, Excision: - Benign phyllodes tumour. - NEGATIVE for malignancy.
Micro
The sections show a well-circumscribed mass with a leaf-like architecture. There is no stromal overgrowth or atypia. Proliferative activity is not readily apparent.
See also
References
- ↑ Guerrero MA, Ballard BR, Grau AM (July 2003). "Malignant phyllodes tumor of the breast: review of the literature and case report of stromal overgrowth". Surg Oncol 12 (1): 27–37. PMID 12689668. http://linkinghub.elsevier.com/retrieve/pii/S0960740403000057.
- ↑ Bannowsky, A.; Probst, A.; Dunker, H.; Loch, T. (2009). "Rare and challenging tumor entity: phyllodes tumor of the prostate.". J Oncol 2009: 241270. doi:10.1155/2009/241270. PMID 20069045.
- ↑ McCluggage, WG. (Mar 2010). "Mullerian adenosarcoma of the female genital tract.". Adv Anat Pathol 17 (2): 122-9. doi:10.1097/PAP.0b013e3181cfe732. PMID 20179434.
- ↑ URL: http://www.breastpathologyconsults.com/blog/wp-content/uploads/2011/03/FEL_poster.pdf. Accessed on: 23 February 2012.
- ↑ Humphrey, Peter A; Dehner, Louis P; Pfeifer, John D (2008). The Washington Manual of Surgical Pathology (1st ed.). Lippincott Williams & Wilkins. pp. 263. ISBN 978-0781765275.
- ↑ Taira N, Takabatake D, Aogi K, et al (October 2007). "Phyllodes tumor of the breast: stromal overgrowth and histological classification are useful prognosis-predictive factors for local recurrence in patients with a positive surgical margin". Jpn. J. Clin. Oncol. 37 (10): 730-6. doi:10.1093/jjco/hym099. PMID 17932112. http://jjco.oxfordjournals.org/cgi/reprint/37/10/730.
- ↑ Dunne B, Lee AH, Pinder SE, Bell JA, Ellis IO (October 2003). "An immunohistochemical study of metaplastic spindle cell carcinoma, phyllodes tumor and fibromatosis of the breast". Hum Pathol 34 (10): 1009–15. doi:10.1053/s0046-8177(03)00414-3. PMID 14608534.